Cargando…
Somatostatin and CXCR4 chemokine receptor expression in hepatocellular and cholangiocellular carcinomas: tumor capillaries as promising targets
BACKGROUND: Hepatocellular (HCC) and cholangiocellular carcinomas (CCC) display an exceptionally poor prognosis. Especially for advanced disease no efficient standard therapy is currently available. Recently, somatostatin analogs have been evaluated for the treatment of HCC, however, with contradict...
Autores principales: | Kaemmerer, Daniel, Schindler, Robin, Mußbach, Franziska, Dahmen, Uta, Altendorf-Hofmann, Annelore, Dirsch, Olaf, Sänger, Jörg, Schulz, Stefan, Lupp, Amelie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745780/ https://www.ncbi.nlm.nih.gov/pubmed/29282035 http://dx.doi.org/10.1186/s12885-017-3911-3 |
Ejemplares similares
-
Inverse expression of somatostatin and CXCR4 chemokine receptors in gastroenteropancreatic neuroendocrine neoplasms of different malignancy
por: Kaemmerer, Daniel, et al.
Publicado: (2015) -
Different somatostatin and CXCR4 chemokine receptor expression in gastroenteropancreatic neuroendocrine neoplasms depending on their origin
por: Mai, Rebekka, et al.
Publicado: (2019) -
Evaluation of Somatostatin and CXCR4 Receptor Expression in a Large Set of Prostate Cancer Samples Using Tissue Microarrays and Well-Characterized Monoclonal Antibodies
por: Werner, Christoph, et al.
Publicado: (2020) -
Evaluation of somatostatin, CXCR4 chemokine and endothelin A receptor expression in a large set of paragangliomas
por: Kaemmerer, Daniel, et al.
Publicado: (2017) -
Comparative evaluation of somatostatin and CXCR4 receptor expression in different types of thyroid carcinoma using well-characterised monoclonal antibodies
por: Czajkowski, Max, et al.
Publicado: (2022)